The Delaware Supreme Court has unanimously ruled that CVS Health cannot recover insurance coverage for its massive opioid-related legal settlements, determining that the underlying lawsuits sought economic damages rather than covered “bodily injury” or “property damage” under the pharmacy chain’s general liability policies. The decision represents a significant victory for insurance companies facing billions in opioid-related claims.

Insurance Coverage Exclusions for Economic Loss Claims

The state’s highest court concluded that thousands of opioid crisis lawsuits against CVS sought compensation for broad economic losses to communities and healthcare systems, not the specific “bodily injury” or “property damage” required for general liability coverage. This distinction proves critical in insurance law, where policy language determines coverage scope and insurer obligations.

The court rejected CVS’s argument that its $5 billion November 2022 settlement demonstrated that underlying claims involved bodily injury. Instead, justices found the settlement addressed the opioid crisis “at-large” without establishing direct connections between damages and specific individualized injuries required for insurance coverage.

Precedent Follows Earlier Rite Aid Ruling

This decision aligns with the Delaware Supreme Court’s 2022 ruling against Rite Aid Corporation in similar opioid insurance coverage litigation. The consistent judicial approach suggests Delaware courts will narrowly interpret general liability coverage when opioid settlements address systemic community harm rather than traditional tort claims for individual injuries.

Billions in Industry Settlements Without Insurance Relief

CVS joins other major pharmacy chains including Walgreens and Walmart that have collectively paid more than $8 billion in opioid crisis settlements. The insurance coverage denials mean these corporations must absorb the massive settlement costs without policy reimbursement, significantly impacting their financial exposure from the ongoing opioid litigation.

Insurance Law and Mass Tort Settlements

This case highlights complex insurance coverage issues arising from mass tort settlements that address widespread societal harm rather than traditional individual injury claims. The ruling may influence how courts nationwide interpret general liability coverage for similar public health crisis settlements.

The decision demonstrates how insurance policy language critically determines coverage availability for corporate legal settlements in mass tort litigation.